Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion type Assertion NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_head.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion description "[Compared with IL-15, RLI displayed better biological activities in vitro and higher antitumor effects in vivo in murine and human cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_provenance.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion evidence source_evidence_literature NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_provenance.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion SIO_000772 25072059 NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_provenance.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion wasDerivedFrom befree-20150227 NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_provenance.
- NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_assertion wasGeneratedBy ECO_0000203 NP673642.RAcFmNAQCYJPQTfVYsxJoRAAgvUFPhxjZCQXuxz-FpOiA130_provenance.